| 产品名称： | Streptoalloteichus hindustanus Tomita et al. |
|---|---|
| 商品货号： | TS178626 |
| Strain Designations： | E465-94 |
| Application： | Produces BMY 28190 BMY-28190 Produces Bu-2231 Production of the antibiotic Bu-2231 |
| Isolation： | Soil |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Bristol Labs. |
| U.S. Patent Number： | |
| References： | Ohkuma H, et al. BMY-28190, a novel antiviral antibiotic complex. J. Antibiot. 41: 849-854, 1988. PubMed: 3417557 Tomita K, et al. Glycopeptide antibiotics Bu-2231 A and B and process for producing same. US Patent 4,051,237 dated Sep 27 1977 Tsukiura H, et al. Fermentation process for producing apramycin and nebramycin Factor V. US Patent 4,032,404 dated Jun 28 1977 |
| Cross References： | Nucleotide (GenBank) : X52869 Streptoalloteichus hindustans ble gene. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Streptoalloteichus hindustanus Tomita et al. |
|---|---|
| 商品货号： | TS178626 |
| Strain Designations： | E465-94 |
| Application： | Produces BMY 28190 BMY-28190 Produces Bu-2231 Production of the antibiotic Bu-2231 |
| Isolation： | Soil |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Bristol Labs. |
| U.S. Patent Number： | |
| References： | Ohkuma H, et al. BMY-28190, a novel antiviral antibiotic complex. J. Antibiot. 41: 849-854, 1988. PubMed: 3417557 Tomita K, et al. Glycopeptide antibiotics Bu-2231 A and B and process for producing same. US Patent 4,051,237 dated Sep 27 1977 Tsukiura H, et al. Fermentation process for producing apramycin and nebramycin Factor V. US Patent 4,032,404 dated Jun 28 1977 |
| Cross References： | Nucleotide (GenBank) : X52869 Streptoalloteichus hindustans ble gene. |
